angiotensin ii has been researched along with carbostyril in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, S; Okada, K; Saito, T | 1 |
| Chihara, T; Kondo, K; Mori, T; Nakamura, S; Ogawa, H; Onogawa, T; Tominaga, M; Yabuuchi, Y; Yamamura, Y | 1 |
| Ishikawa, S; Okada, K; Saito, T; Sasaki, R | 1 |
| Louis, S; Saward, L; Zahradka, P | 1 |
| Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y | 1 |
5 other study(ies) available for angiotensin ii and carbostyril
| Article | Year |
|---|---|
Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium; Cells, Cultured; Kinetics; Male; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin | 1991 |
OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Animals; Arginine Vasopressin; Binding, Competitive; Blood Pressure; Cell Membrane; Kidney; Kinetics; Liver; Norepinephrine; Piperidines; Quinolones; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Time Factors | 1991 |
Distinct inhibition by non-peptide and peptide arginine vasopressin antagonists of vasopressin-induced activation of mitogen-activated protein kinase in cultured rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Ionomycin; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Tetradecanoylphorbol Acetate | 1994 |
Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Focal Adhesion Protein-Tyrosine Kinases; Imidazoles; Losartan; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Kinase Inhibitors; Pyridines; Quinolones; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sulfones; Swine; Time Factors | 2011 |
Angiotensin IV attenuates diabetic cardiomyopathy
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left | 2021 |